Man Group plc - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 72 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.

Quarter-by-quarter ownership
Man Group plc ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$3,659,000
+63.4%
30,897
+41.0%
0.02%
+45.5%
Q2 2020$2,239,000
+45.8%
21,912
+53.9%
0.01%
+10.0%
Q1 2020$1,536,000
-91.5%
14,234
-90.8%
0.01%
-83.3%
Q4 2019$18,103,000
+143.0%
155,561
+139.0%
0.06%
+114.3%
Q3 2019$7,451,000
+62.2%
65,092
+7.5%
0.03%
+40.0%
Q4 2018$4,595,000
+6.1%
60,540
+11.9%
0.02%
+25.0%
Q3 2018$4,330,000
-45.5%
54,120
-32.4%
0.02%
-51.5%
Q2 2018$7,950,00080,0370.03%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders